Aviya Oz
About Aviya Oz
Aviya Oz is a Clinical Variant Scientist at Variantyx, where she has worked since 2021. She holds a Master of Science in Genetic Counseling from The Hebrew University of Jerusalem and a Bachelor of Science in Biology from Ben-Gurion University of the Negev.
Work at Variantyx
Aviya Oz serves as a Clinical Variant Scientist at Variantyx, a position she has held since 2021. In this role, she focuses on analyzing genetic variants and their implications for clinical practice. Her work contributes to the understanding of genetic conditions and aids in the development of personalized medicine approaches. Variantyx is known for its innovative solutions in genomic data interpretation, and Oz's expertise plays a critical role in advancing the company's mission.
Education and Expertise
Aviya Oz obtained her Master of Science in Genetic Counseling from The Hebrew University of Jerusalem, where she studied from 2014 to 2016. Prior to that, she earned a Bachelor of Science in Biology from Ben-Gurion University of the Negev, completing her studies from 2009 to 2011. Her educational background provides her with a solid foundation in genetics and counseling, equipping her with the necessary skills to excel in her current role.
Background
Aviya Oz has a background in genetics and counseling, with formal education in both fields. She worked as a Teaching Assistant at Hadassah Academic College from 2015 to 2016, where she supported the academic development of students in the Jerusalem Area, Israel. This experience contributed to her understanding of educational methodologies and reinforced her commitment to the field of genetic counseling.
Professional Experience
Prior to her current position at Variantyx, Aviya Oz gained valuable experience as a Teaching Assistant at Hadassah Academic College. During her tenure from 2015 to 2016, she engaged with students and contributed to their learning in the field of genetics. This role enhanced her communication skills and deepened her understanding of genetic concepts, which she applies in her current work as a Clinical Variant Scientist.